Welcome to our dedicated page for Huron Consul SEC filings (Ticker: HURN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Huron Consulting Group Inc. filings document the financial reporting, governance and capital-structure disclosures of a public professional services firm. Recent Form 8-K reports furnish quarterly and annual operating results, non-GAAP measures, guidance commentary and segment information for the Healthcare, Education and Commercial businesses.
The company's proxy materials cover board matters, executive compensation, performance-based stock units and options, shareholder voting items and corporate governance. Other material-event filings describe financing arrangements, including senior secured revolving credit and term loan facilities, along with exhibits and Inline XBRL cover-page data associated with Huron's regulatory reporting.
Debra Zumwalt, a director of Huron Consulting Group Inc. (HURN), reported a sale of 170 shares of the company's common stock on 08/14/2025 at a price of $135.38 per share. The sale was executed automatically under a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2025. After the reported transaction, the filing shows the reporting person beneficially owned 26,809 shares. The Form 4 was signed on behalf of Ms. Zumwalt by an attorney-in-fact on 08/18/2025. The filing discloses a routine, pre-planned disposition rather than an ad hoc trade.
Huron Consulting Group Inc. (HURN) director Ekta Singh-Bushell reported a sale of 126 shares of the company's common stock on 08/14/2025 at a price of $135.38 per share. The sale was executed automatically under a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2025. After the transaction, the reporting person beneficially owned 15,467 shares. The Form 4 was filed as an individual reporting person and signed on behalf of the reporting person by an attorney-in-fact.
Huron Consulting Group Inc. (HURN) Form 4: The company's Chief Accounting Officer, Kyle Featherstone, reported the sale of 375 shares of HURN common stock on 08/14/2025 at a price of $135.73 per share. After this transaction he beneficially owned 1,311 shares, held directly. The form was signed by an attorney-in-fact on 08/18/2025.
Huron Consulting Group, Inc. (HURN) filed a Form 144 notice reporting a proposed sale of 126 shares of common stock through Fidelity Brokerage Services LLC on the NASDAQ. The shares have an aggregate market value of $17,057.88 based on the filing and represent a small fraction of the 17,306,887 shares outstanding. The filing states the shares were acquired on 08/14/2025 via restricted stock vesting from the issuer and that payment is characterized as compensation. No sales in the prior three months were reported.
Form 144 notice for HURN: The filer notified a proposed sale of 375 common shares held at Fidelity Brokerage Services, with an aggregate market value of $50,898.75. The shares represent part of restricted stock that vested in two tranches: 60 shares on 01/01/2025 and 315 shares on 03/01/2025, both acquired as compensation. The filing lists total outstanding shares as 17,306,887 and identifies the intended sale date as 08/14/2025 on NASDAQ. The filer certifies they are not aware of undisclosed material adverse information and notes no securities sold by the filer in the past three months.
The filing is a Form 144 notice relating to proposed sale of 170 shares of common stock of Huron Consulting Group Inc. (HURN). The shares were acquired on 07/01/2025 by restricted stock vesting from the issuer as compensation. The planned transaction is to be executed through Fidelity Brokerage Services LLC on NASDAQ with an approximate sale date of 08/14/2025 and an aggregate market value reported as $23,014.60. The filing reports 17,306,887 shares outstanding for the class and indicates no sales in the past three months by the selling person.
Huron Consulting Group Inc. (HURN) – Form 4 insider transaction
- Reporting person: James H. Roth, Director
- Transaction date: 08/06/2025
- Type: Open-market sales executed under a pre-arranged Rule 10b5-1 plan adopted 05/08/2025
- Total shares sold: 2,000 common shares across four trades
- Price ranges: $126.60–$130.37; weighted-average prices disclosed for each lot (208 @ $126.76, 448 @ $128.29, 817 @ $129.23, 527 @ $130.07)
- Post-sale holdings: 43,304 shares directly and 3,855 shares indirectly via a family LLC (total 47,159)
- % of direct holdings sold: ≈4.4% of pre-sale direct position (45,304)
No derivative security transactions were reported.